Literature DB >> 1654074

Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working Party.

P M Fayers1, N M Bleehen, D J Girling, R J Stephens.   

Abstract

Three hundred and sixty-nine patients in an MRC study of combination chemotherapy and radiotherapy for small-cell lung cancer of limited extent were asked to complete a Daily Diary Card which enabled an assessment of their quality of life to be made during and after treatment. The information derived from the card suggests that although cytotoxic chemotherapy has an adverse effect upon quality of life, this impairment only affects the first 2 or 3 days following each course of treatment, although there is also a small deterioration which may be associated with the 'nadir' effect of the blood counts about 10 days after each course. These results should assist physicians in counselling patients about the likely effects of treatment. Just over half of the patients (196) were subsequently randomised to either a further six courses of maintenance chemotherapy or no further chemotherapy, and it is also shown that the patients allocated to no maintenance chemotherapy experienced a gradually deteriorating quality of life, as opposed to the brief but more severe adverse effects which occurred following each course in the maintenance chemotherapy group; this supports the hypothesis of a palliative effect in this latter group. The findings demonstrate that the Daily Diary Card is a sensitive instrument capable of yielding useful information.

Entities:  

Mesh:

Year:  1991        PMID: 1654074      PMCID: PMC1977498          DOI: 10.1038/bjc.1991.296

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Health status: types of validity and the index of well-being.

Authors:  R M Kaplan; J W Bush; C C Berry
Journal:  Health Serv Res       Date:  1976       Impact factor: 3.402

2.  Quality of life in cancer trials.

Authors:  D Brinkley
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-14

3.  Measurement of the clinical status of patients with breast cancer: evidence for the validity of self assessment with linear analogue scales.

Authors:  N F Boyd; P J Selby; H J Sutherland; S Hogg
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

4.  Quality of life measurements in patients with malignant disease: a review.

Authors:  A Clark; L J Fallowfield
Journal:  J R Soc Med       Date:  1986-03       Impact factor: 5.344

5.  Qualms about QALYs.

Authors:  A Smith
Journal:  Lancet       Date:  1987-05-16       Impact factor: 79.321

Review 6.  Measuring and analysing quality of life in cancer clinical trials: a review.

Authors:  P M Fayers; D R Jones
Journal:  Stat Med       Date:  1983 Oct-Dec       Impact factor: 2.373

7.  Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial.

Authors:  D M Geddes; L Dones; E Hill; K Law; P G Harper; S G Spiro; J S Tobias; R L Souhami
Journal:  Eur J Cancer       Date:  1990-04       Impact factor: 9.162

8.  Scientific and clinical problems in indexes of functional disability.

Authors:  A R Feinstein; B R Josephy; C K Wells
Journal:  Ann Intern Med       Date:  1986-09       Impact factor: 25.391

9.  Do psychological studies upset patients?

Authors:  L J Fallowfield; M Baum; G P Maguire
Journal:  J R Soc Med       Date:  1987-01       Impact factor: 18.000

10.  The development of a method for assessing the quality of life of cancer patients.

Authors:  P J Selby; J A Chapman; J Etazadi-Amoli; D Dalley; N F Boyd
Journal:  Br J Cancer       Date:  1984-07       Impact factor: 7.640

View more
  16 in total

1.  Economic and quality-of-life aspects of treating small cell lung cancer.

Authors:  P Graham; J Boyages
Journal:  Pharmacoeconomics       Date:  1993-06       Impact factor: 4.981

2.  Quality-of-life assessment in small cell lung cancer.

Authors:  P Fayers
Journal:  Pharmacoeconomics       Date:  1992-09       Impact factor: 4.981

Review 3.  Evaluation of quality of life for diverse patient populations.

Authors:  K R Yabroff; B P Linas; K Schulman
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.

Authors:  L Maslove; N Gower; S Spiro; R Rudd; R Stephens; P West
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

Review 5.  Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.

Authors:  Rosemary Stevens; Fergus Macbeth; Elizabeth Toy; Bernadette Coles; Jason F Lester
Journal:  Cochrane Database Syst Rev       Date:  2015-01-14

Review 6.  Quality of life as an outcome in breast cancer. Clinical application.

Authors:  J Bonneterre; S Schraub; S Lecomte; M Mercier
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

Review 7.  MRC quality of life studies using a daily diary card--practical lessons learned from cancer trials.

Authors:  P Fayers
Journal:  Qual Life Res       Date:  1995-08       Impact factor: 4.147

8.  Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life.

Authors:  S G Spiro; R M Rudd; R L Souhami; J Brown; D J Fairlamb; N H Gower; L Maslove; R Milroy; V Napp; M K B Parmar; M D Peake; R J Stephens; H Thorpe; D A Waller; P West
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

9.  Development and Validation of the Quality-of-Life Assessment System for Lung Cancer Based on Traditional Chinese Medicine.

Authors:  Chonghua Wan; Shengfu You; Peng Quan; Yi Song; Tao Liu; Jingen Lu; Peiyong Zheng
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-12       Impact factor: 2.629

10.  Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial.

Authors:  Francesco Nuzzo; Alessandro Morabito; Adriano Gravina; Francesca Di Rella; Gabriella Landi; Carmen Pacilio; Vincenzo Labonia; Emanuela Rossi; Ermelinda De Maio; Maria Carmela Piccirillo; Giuseppe D'Aiuto; Renato Thomas; Massimo Rinaldo; Gerardo Botti; Maurizio Di Bonito; Massimo Di Maio; Ciro Gallo; Francesco Perrone; Andrea de Matteis
Journal:  BMC Cancer       Date:  2011-02-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.